Tofacitinib Citrate Tablets Reference Listed Drug

* Please be kindly noted products are supplied for RLD supplies/ Reference listed drugs/ Comparator Drug Clinical trials. We do not sell to patients.

 

Name	Tofacitinib Citrate Tablets
Trade name	Xeljanz
Specifications	5mg
Dosage form	tablet
Licensee	PF PRISM C.V.
Remarks	Original research import

Tofacitib citrate tablets are the first JAK pathway inhibitor with a mechanism of action and a new type of oral protein tyrosine kinase inhibitor. Since the product was first approved for marketing in the United States on November 6, 2012, it has been approved for marketing in more than 50 countries and regions around the world, including the United States, Japan, Russia, Australia, and Canada. Tofacitinib citrate tablets are suitable for the sole treatment or additive treatment of partial epilepsy in adults. It can be used for the sole treatment of partial epilepsy in children over 4 years old and the additive treatment of partial epilepsy in children over 2 years old.

We are a global professional manufacturer and supplier of reference drug products, featuring high-quality services and competitive prices. You can get the most favorable reference drug prices here. If you need customized services, please contact us immediately.

Hot Tags: Tofacitinib Citrate Tablets Reference Listed Drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Alfacalcidol Soft Capsules, Argatroban Injection, Acarbose Tablets, Agomelatine Tablets, Esomeprazole Magnesium Enteric Coated Capsules, AdapaleneGel

• Previous: Tolterodine Tartrate Sustained Release Capsules Reference Listed Drug
• Next: Amlodipine Besylate And Atorvastatin Calcium Tablets Reference Listed Drug